BARCELONA, Spain — Adopting specific treatment regimens, reducing patient and staff travel, and limiting the use of unnecessary personal protective equipment can help improve the carbon footprint of ...
The current standards of care involve using anti-VEGF agents, which selectively target extracellular VEGF. We've been doing this for years and those drugs do a good job, but there are limitations ...
Resveratrol supplementation in wet AMD patients led to fewer aflibercept injections and reduced macular fibrosis progression over two years. Both treatment groups showed significant improvements in ...
STOCKHOLM -- Two VEGF-targeting gene therapies for neovascular age-related macular degeneration (nAMD) substantially reduced treatment burden while preserving visual acuity, according to results ...
Please provide your email address to receive an email when new articles are posted on . SAR446597 is designed to inhibit C1s and factor Bb in the complement pathway. Fast track designation expedites ...
Intravitreal injections of anti-VEGF were associated with a small but significant increase in the risk for stroke among patients with neovascular age-related macular degeneration. The risk was higher ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback